Australia is closely watching the arrival of retatrutide, a novel dual GIP and GLP-1 receptor therapy, representing a potential advance in weight loss . Early study data have demonstrated impressive results, https://deweycayy017367.life3dblog.com/42032544/new-treatment-in-australia-a-new-solution-for-weight-loss